Browsing: Pharmaceuticals

(Reuters) -Vanda Pharmaceuticals on Monday rejected UK-based Cycle Pharmaceuticals’ second takeover proposal, which values the drugmaker at $8 per share…

SUNPHARMA Elliott Wave technical analysis Function: Larger Degree Trend Higher (Intermediate Degree orange). Mode: Motive. Structure: Impulse. Position: Minute Wave ((v))…

SAN DIEGO – In a recent transaction on September 23, Andrew Reardon, the Chief Legal Officer (CLO) and Secretary of…

In a recent transaction, Hongbo Lu, a director at Terns Pharmaceuticals, Inc. (NASDAQ:TERN), purchased a significant amount of the company’s…

Rigel (NASDAQ:) Pharmaceuticals, Inc. (NASDAQ: RIGL) has released its financial results for the second quarter of 2024, highlighting significant sales…

Atea Pharmaceuticals, a biopharmaceutical company focused on developing therapeutics for viral diseases, has announced notable advancements in its clinical trials…

Mirum Pharmaceuticals (ticker: NASDAQ:) has reported a significant increase in financial results for the first quarter of 2024, with net…

Enanta Pharmaceuticals (NASDAQ: NASDAQ:), a biopharmaceutical company focused on developing oral therapeutics, reported its financial results for the fiscal second…

In the fast-paced world of biotechnology, companies like BioMarin Pharmaceutical Inc. (NASDAQ:) are at the forefront of developing therapies for…

Explore Wall Street’s expert insights with this ProResearch article, which will exclusively be available to InvestingPro subscribers soon. Dive deeper…